FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer

Autor: Margarita Kirienko 1, Francesca Gallivanone 2, Martina Sollini 1, Giulia Veronesi 3, Emanuele Voulaz 3, Lidjia Antunovic 4, Lorenzo Leonardi 4, Giorgio Testanera 4, Isabella Castiglioni 2, Arturo Chiti 1, 4

Publikováno v: Scopus-Elsevier
Frontiers in bioscience (Online) 22 (2017): 1713–1723. doi:10.2741/4567
info:cnr-pdr/source/autori:Margarita Kirienko 1, Francesca Gallivanone 2, Martina Sollini 1, Giulia Veronesi 3, Emanuele Voulaz 3, Lidjia Antunovic 4, Lorenzo Leonardi 4, Giorgio Testanera 4, Isabella Castiglioni 2, Arturo Chiti 1,4/titolo:FDG PET%2FCT as theranostic imaging in diagnosis of non-small cell lung cancer/doi:10.2741%2F4567/rivista:Frontiers in bioscience (Online)/anno:2017/pagina_da:1713/pagina_a:1723/intervallo_pagine:1713–1723/volume:22

Objective of this work was to evaluate the role of 18F-fluorodeoxyglucose (FDG) positron-emission tomography features as theranostic imaging biomarkers in non-small cell lung cancer. In a retrospective protocol, 31 stage I-III NSCLC patients were enr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73fedafe017b80fc081082221f6a18f7
https://pubmed.ncbi.nlm.nih.gov/28410141